Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Diabetic Retinopathy Clinical Trials

81 recruiting trials for Diabetic Retinopathy. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
81
Total Trials
81
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT03752840

Village-Integrated Eye Worker Trial II

The vast majority of blindness is avoidable. The World Health Organization (WHO) estimates that 80% of cases of visual impairment could be prevented or reversed with early...

Sponsor: University of California, San FranciscoEnrolling: 602001 location
RECRUITINGNCT05883072

Exploring the Effectiveness of AI Generative Models for Diabetic Patients

We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient

Sponsor: Pakistan Council of Scientific and Industrial ResearchEnrolling: 3001 location
RECRUITINGNCT02026843

Analysis of Biomarkers From Patients With Chorioretinal Diseases

This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases,...

Sponsor: Kyungpook National University HospitalEnrolling: 1001 location
RECRUITINGNCT06955611

Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?

To assess a pathway using opticians based in their practices and a 'virtual' review by a consultant ophthalmologist, based in the hospital to assess suspected diabetic...

Sponsor: Hywel Dda Health BoardEnrolling: 1501 location
RECRUITINGPhase 3NCT06305416

A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

Macular edema in diabetes, defined as retinal thickening within two disc diameters of the center of the macula, results from retinal microvascular changes that compromise the...

Sponsor: Incepta Pharmaceuticals LtdEnrolling: 701 location
RECRUITINGNCT07222293

Assessment of AI Program 'DRISTi' as a Screening Tool

A study will be conducted to demonstrate that DRISTi will correctly diagnose Diabetic Retinopathy (e.g., mtmDR, PDR, DME) in eyes of patients with diabetes. Participants who have...

Sponsor: Artelus AIEnrolling: 9002 locations
RECRUITINGNCT03713268

Intraoperative OCT Guidance of Intraocular Surgery II

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery,...

Sponsor: Duke UniversityEnrolling: 2621 location
RECRUITINGNCT05704491

AI Screening for Diabetic Retinopathy

The increasing prevalence of diabetes mellitus represents a major health problem, especially since around 40% of diabetic patients develop diabetic retinopathy, which severely...

Sponsor: West German Center of Diabetes and HealthEnrolling: 1001 location
RECRUITINGNCT06439576

Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular...

The Farseeing Study will explore long-term effectiveness, safety, and treatment patterns among patients being treated with faricimab in real-world, routine clinical practice in...

Sponsor: Hoffmann-La RocheEnrolling: 100020 locations
RECRUITINGNCT06610747

Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT

Diabetic macular edema (DME) is a common cause of central visual loss in diabetic patients and a global public health burden around the world. Most patients with DME and vision...

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen UniversityEnrolling: 3083 locations
RECRUITINGNCT06269419

Study of Natural Course Progression of Diabetic Retinopathy

The goal of this observational study is to observe the formation and development of the non-perfusion area of diabetic retinopathy in the posterior area of the retina in type 2...

Sponsor: Jie LiEnrolling: 2001 location
RECRUITINGPhase 3NCT04661358

Fenofibrate for Prevention of DR Worsening

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with...

Sponsor: Jaeb Center for Health ResearchEnrolling: 56020 locations
RECRUITINGNCT03403686

Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

Results from large clinical trials demonstrate a strong association between lipid abnormalities and progression of the most common microvascular complication, diabetic retinopathy...

Sponsor: University of Alabama at BirminghamEnrolling: 1041 location
RECRUITINGNCT06892353

AI-Powered DIY Screening System for Diabetic Retinopathy

A pragmatic trial will be conducted in two representative clinics in each of the three types of targeted settings. It will be run for 3 months in each clinic to complete data...

Sponsor: The Hong Kong Polytechnic UniversityEnrolling: 5001 location
RECRUITINGNCT07468058

Diabetic Retinopathy Prevalence And Risk Factors

The goal of this retrospective observational study is to evaluate the prevalence and severity of diabetic retinopathy (DR) and to identify associated risk factors among patients...

Sponsor: Da Nang Family General HospitalEnrolling: 3001 location
RECRUITINGPhase 2NCT07259928

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

The goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non-proliferative...

Sponsor: Annexin Pharmaceuticals ABEnrolling: 121 location
RECRUITINGPhase 2 / Phase 3NCT06595355

Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin

The purpose of this study is to evaluate the effectiveness of adding curcumin oral treatment to bevacizumab intravitreal injection in patients with central macular edema. A blind...

Sponsor: Isfahan University of Medical SciencesEnrolling: 521 location
RECRUITINGNCT06843499

Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease...

This study aims to evaluate the effectiveness of an artificial intelligence (AI)-assisted screening system in ophthalmic diagnosis. Using AI-based fundus photography, the system...

Sponsor: National Taiwan University HospitalEnrolling: 10001 location
RECRUITINGNCT07245082

Patients With Type 2 Diabetes

Diabetes mellitus

Sponsor: National Taiwan University HospitalEnrolling: 20001 location
RECRUITINGNCT07236879

Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care

This is a clinical trial to evaluate the effects of universal screening for diabetic retinopathy (DR) and diabetic macular edema (DME) using artificial intelligence (AI) in the...

Sponsor: Hospital de Clinicas de Porto AlegreEnrolling: 9221 location
RECRUITINGNCT07458516

Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients

The purpose of this clinical study is to explore imaging, functional and systemic biomarkers of diabetic retinopathy (DR) progression, in Type 2 Diabetes (T2D) patients with...

Sponsor: Association for Innovation and Biomedical Research on Light and ImageEnrolling: 1001 location
RECRUITINGNCT06582472

Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy

Despite the evidence that diabetic retinopathy (DR) remains the first cause of blindness among the working-age population, it lacks a specific preventive treatment. This is...

Sponsor: IRCCS Ospedale San RaffaeleEnrolling: 1802 locations
RECRUITINGNCT06264427

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

The goal of this clinical trial is to perform a detailed description of the feno- and genotype of people living with type 2 diabetes and severe obesity who are linked to care at...

Sponsor: Steno Diabetes Center GreenlandEnrolling: 10001 location
RECRUITINGEarly Phase 1NCT06593405

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies...

Sponsor: MCPHS UniversityEnrolling: 501 location
RECRUITINGNCT06899529

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

Patients undergoing surgery for complications related to diabetes will be recruited.

Sponsor: Christian Ophthalmic Surgery Expedition NetworkEnrolling: 1501 location
RECRUITINGNCT06914778

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and...

Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye...

Sponsor: Hywel Dda Health BoardEnrolling: 1201 location
RECRUITINGPhase 4NCT07456826

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution...

This Phase 4, multicenter, randomized, double-masked clinical study evaluates the efficacy and safety of chloroprocaine hydrochloride ophthalmic gel 3% (IHEEZO) compared with...

Sponsor: Harrow IncEnrolling: 2361 location
RECRUITINGPhase 4NCT06662994

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Patients with diabetic macular edema (DME) sometimes must undergo vitrectomy surgery (PPV) for diabetic and non-diabetic related issues. Patients may have improved DME with...

Sponsor: Retina Consultants of Orange CountyEnrolling: 151 location
RECRUITINGNCT06257082

Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities

An online survey (n=1,500) and 4 focus groups will be conducted with Latinx patients with diabetes (n=20) to obtain preliminary data regarding whether and how patient and...

Sponsor: University of Wisconsin, MadisonEnrolling: 15261 location
RECRUITINGNCT04240652

The Diabetic Retinopathy Screening, Prevention and Control Program

The greatest harm of diabetes is various acute and chronic complications, especially diabetic retinopathy(DR), leading to extremely high rates of disability and blindness. Early...

Sponsor: Shanghai Jiao Tong University School of MedicineEnrolling: 5000002 locations
RECRUITINGNCT06124586

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

The planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness...

Sponsor: Heinrich-Heine University, DuesseldorfEnrolling: 2001 location
RECRUITINGNCT07296952

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy...

This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic...

Sponsor: University of Illinois at ChicagoEnrolling: 601 location
RECRUITINGNCT07255326

Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes

The aim of this clinical trial is to learn if omega-3 fatty acid supplements help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. It will also learn...

Sponsor: University of FaisalabadEnrolling: 801 location
RECRUITINGPhase 3NCT07235085

A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative...

The purpose of this trial is to study the safety and effectiveness of OTX-TKI (axitinib intravitreal hydrogel) for the treatment of Non-Proliferative Diabetic Retinopathy....

Sponsor: Ocular Therapeutix, Inc.Enrolling: 9301 location
RECRUITINGNCT06968637

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply...

The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of...

Sponsor: OrbisEnrolling: 3362 locations
RECRUITINGNCT07135570

"My Eyes, My Light": Amar Chokh, Amar Alo

Eye disease affects 2.2 billion people globally, which in turn adversely affects schooling, economic productivity, and participation in social life. The primary conditions...

Sponsor: Data Yakka, Inc.Enrolling: 200001 location
RECRUITINGEarly Phase 1NCT04008121

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

The objective of this study is to evaluate the safety and image quality of the investigational dye, MB-102, compared to the control dye (fluorescein sodium) in healthy and...

Sponsor: MediBeaconEnrolling: 101 location
RECRUITINGNCT07015034

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

In this cohort study, the investigators will test vision screenings in Danish general practice for patients over 70 years of age with minimum one chronic condition. The main...

Sponsor: University of CopenhagenEnrolling: 4602 locations
RECRUITINGNCT06821399

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

This study aims to integrate clinical indicators and features of fundus images, combined with metabolomics, to construct an early warning model for diabetic retinopathy (DR) in...

Sponsor: Yufan WangEnrolling: 29203 locations
RECRUITINGNCT06478407

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection...

Sponsor: Li XiaorongEnrolling: 180001 location
RECRUITINGPhase 1 / Phase 2NCT06787482

Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies

Summary of the Study This clinical trial evaluates a novel peptide-based therapy for treating retinal dystrophies, age-related macular degeneration (AMD), and diabetic retinopathy...

Sponsor: Ace Cells Lab LimitedEnrolling: 1002 locations
RECRUITINGNCT07351786

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

This study aims to test the impact of new-generation anti-diabetic drugs, such as SGLT2 inhibitors and DPP-4 inhibitors, on the development of diabetic retinopathy (DR). The study...

Sponsor: Sara A BelalEnrolling: 701 location
RECRUITINGNCT07002372

Effect of Video Viewing on Intravitreal Injection Experience

Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 1821 location
RECRUITINGNCT05079399

Biomarker of Diabetic Retinopathy

Diabetic retinopathy (DR) is a complication of diabetes in which blood vessels supplying blood to the back of the eye (retina) are dysfunctional. This can lead to an improper...

Sponsor: Indiana UniversityEnrolling: 1923 locations
RECRUITINGNCT06287645

Color Fundus Photograph With Experts Labelling

This trial aims to provide a digital retinal image dataset from Pakistan, graded by three specialists according to the severity of Diabetic Retinopathy. The dataset aims to...

Sponsor: Pakistan Council of Scientific and Industrial ResearchEnrolling: 500001 location
RECRUITINGPhase 2NCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of...

Sponsor: Boehringer IngelheimEnrolling: 17820 locations
RECRUITINGNCT06629649

Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers

The goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants...

Sponsor: University of Alabama at BirminghamEnrolling: 18001 location
RECRUITINGNCT03135327

Clinical Applications of Advanced Ophthalmic Imaging

The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager...

Sponsor: University of MiamiEnrolling: 50001 location
RECRUITINGNCT06074731

Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and...

Sponsor: Johannes Kepler University of LinzEnrolling: 5001 location
RECRUITINGNCT06549023

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal photocoagulation...

Sponsor: Vastra Gotaland RegionEnrolling: 401 location

Showing 50 of 81 trials.Search all Diabetic Retinopathy trials